Endologix to Present at the Friedman Billings Ramsey Spring Investor Conference
May 21 2008 - 3:00AM
Business Wire
Endologix, Inc. (Nasdaq:ELGX) today announced that President and
Chief Executive Officer John McDermott will make a presentation to
the investment community at the Friedman Billings Ramsey 12th
Annual Spring Investor Conference on Wednesday, May 28 at 2:15 p.m.
Eastern time (11:15 a.m. Pacific time). This conference will be
held at The Grand Hyatt New York. Interested investors may gain
access to a live audio webcast and slide presentation via the
Internet by visiting the Company�s Web site at www.endologix.com.
Please go to the Interviews/Presentations page on the Investor
Relations section of the Web site. The presentation will be
available and archived on the Web site for 30 days. About Endologix
Endologix, Inc. develops and manufactures minimally invasive
treatments for vascular diseases. Endologix's Powerlink System is
an endoluminal stent graft (ELG) for treating abdominal aortic
aneurysms (AAA). AAA is a weakening of the wall of the aorta, the
largest artery in the body, resulting in a balloon-like
enlargement. Once AAA develops, it continues to enlarge and, if
left untreated, becomes increasingly susceptible to rupture. The
overall patient mortality rate for ruptured AAA is approximately
75%, making it a leading cause of death in the U.S. Additional
information can be found on Endologix�s Web site at
www.endologix.com.
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jul 2023 to Jul 2024